MP-214

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MP-214, covering 2021-04-12 to 2021-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia [Phase 2, Phase 3]